Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Phase III trial of Bayer and Regeneron's eye drug begins in China

eight weeks after an initial loading regimen was equivalent to Roche's anti-VEGF drug Lucentis (ranibizumab), the current standard of care for wet AMD which is injected every four weeks. ... In July, a two-year study reported by the US National

NICE against new indication for Novartis' Lucentis

NICE has come out against the use of Novartis' eye care drug Lucentis (ranibizumab injection) in new indication in England and Wales. ... NICE will now consult on its draft guidance for Lucentis, with final guidance likely to be published in March 2012.

Regeneron's eye disorder drug Eylea wins US approval

FDA licences Lucentis competitor to treat patients with wet age-related macular degeneration. ... Current treatments for the disorder include Lucentis (ranibizumab injection), which is marketed in the US by Genentech/Roche and elsewhere by Novartis.

Interview: Joseph Jimenez, Novartis

Interview: Joseph Jimenez, Novartis In 2010, we had 13 key product approvals and 16 major filings in pharma, including Gilenya, Lucentis and Afinitor," he points out. ... populations. "In Q2 alone, we had four major approvals and two major filings, including Afinitor, Arcapta Neohaler,

Currency rates affect Roche's Q3 results

Regionally, the company saw growth of 1 per cent in US pharmaceutical sales, driven mainly by Lucentis, Rituxan and Actemra, although sales in Western Europe decreased by 4 per cent.

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....